KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $151,858 | -38.8% | 10,925 | +1.3% | 0.00% | -100.0% |
Q2 2023 | $247,947 | -33.8% | 10,785 | -14.7% | 0.00% | 0.0% |
Q1 2023 | $374,671 | +18.7% | 12,645 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $315,619 | -22.3% | 12,645 | -32.3% | 0.00% | 0.0% |
Q3 2022 | $406,000 | +10.3% | 18,665 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $368,000 | -2.6% | 18,665 | +108.9% | 0.00% | 0.0% |
Q1 2022 | $378,000 | -33.3% | 8,935 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $567,000 | +18.1% | 8,935 | +9.4% | 0.00% | 0.0% |
Q3 2021 | $480,000 | – | 8,171 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |